94.1%
metastatic castration-resistant prostate cancerLutatherainoperable or metastatic gastro-enteropancreatic neuroendocrine tumours177Lu-oxodotreotidePluvicto177Lu-PSMALutetium-177177Lu
…rmaceuticals such as Pluvicto (177Lu-PSMA) for the treatment of metastatic castration-resistant prostate cancer and Lutathera (177Lu-oxodotreotide) for inoperable or metastati…